PIK3CA mutations and amplification in endometrioid endometrial carcinomas: Relation to other genetic defects and clinicopathologic status of the tumors

Human Pathology

Volumn 42, Issue 11, 2011, Pages 1710-1719

  Konopka, Bozena ^a   Janiec Jankowska, Aneta ^a   Kwiatkowska, Ewa ^a   Najmoła, Urszula ^a   Bidziński, Mariusz ^a   Olszewski, Włodzimierz ^a   Goluda, Cyprian ^b  

^a INSTITUTE OF ONCOLOGY   (Poland)

^b WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Amplification; Endometrial carcinoma; Hyperplasia; Mutation; PIK3CA; PTEN

Indexed keywords

BETA CATENIN; K RAS PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE 3CA; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ARTICLE; CANCER GRADING; CANCER STAGING; ENDOMETRIOID ENDOMETRIUM CARCINOMA; ENDOMETRIUM CARCINOMA; ENDOMETRIUM HYPERPLASIA; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC DISORDER; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION;

ADULT; AGED; AGED, 80 AND OVER; BETA CATENIN; CARCINOMA, ENDOMETRIOID; ENDOMETRIAL HYPERPLASIA; ENDOMETRIAL NEOPLASMS; FEMALE; GENE AMPLIFICATION; GENES, RAS; HUMANS; MIDDLE AGED; MUTATION; PHOSPHATIDYLINOSITOL 3-KINASES; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PTEN PHOSPHOHYDROLASE;

EID: 80054690349     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2010.01.030     Document Type: Article

References (35)

1. A. Klippel, M.A. Escobedo, and M.S. Wachowicz Activation of phosphatidylinositol 3-kinase is sufficient for cell cycle entry and promotes cellular changes characteristic of oncogenic transformation Mol Cell Biol 18 1998 5699 5711 (Pubitemid 28450521)
2. J.A. Fresno Vara, E. Casado, J. de Castro, P. Cejas, C. Belda-Iniesta, and M. Gonzáles-Barón PIK3K/Akt signaling pathway and cancer Cancer Treat Rev 30 2004 193 204 Review
3. V. Stambolic, A. Suzuki, and J.L. de la Pompa Negative Regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN Cell 95 1998 29 39 (Pubitemid 28458022)
4. B.H. Jiang, and L.Z. Liu PI3K/PTEN signaling in tumorigenesis and angiogenesis Biochim Biophys Acta 1784 2008 150 158
5. Y. Samuels, L.A. Diaz, and O. Schmid-Kittler Mutant PIK3CA promotes cell growth and invasion of human cancer cells Cancer Cell 7 2005 561 573 (Pubitemid 40799249)
6. A.G. Bader, S. Kang, and P.K. Vogt Cancer-specific mutations in PIK3CA are oncogenic in vivo Proc Natl Acad Sci U S A 103 2006 1475 1479 (Pubitemid 43191190)
7. Y. Samuels, Z. Wang, and A. Bardelli High frequency of mutations of the PIK3CA gene in human cancers Science 304 2004 554 (Pubitemid 38541907)
8. I.G. Campbell, S.E. Russel, and D.Y.H. Choong Mutation of the PIK3CA gene in ovarian and breast cancer Cancer Res 64 2004 7678 7681 (Pubitemid 39446895)
9. H. Yamamoto, H. Shimematsu, and M. Nomura PIK3CA mutations and copy number gains in human lung cancers Cancer Res 68 2008 6913 6921
10. M. Gymnopoulos, M.A. Elslige, and P.K. Vogt Rare cancer-specific mutations in PIK3CA show gain of function Proc Natl Acad Sci U S A 104 2007 5569 5574 (Pubitemid 47175721)
11. Y. Kanamori, J. Kigawa, and H. Itamochi Correlation between loss of PTEN expression and Akt phosphorylation in endometrial carcinoma Clin Cancer Res 7 2001 892 895 (Pubitemid 32708726)
12. B. Konopka, Z. Paszko, A. Janiec-Jankowska, and M. Goluda Assessment of the quality and frequency of mutations in PTEN gene in endometrial carcinomas and hyperplasias Cancer Lett 178 2002 43 51 (Pubitemid 34159240)
13. J.I. Risinger, A.K. Hayes, A. Berchuck, and J.C. Barrett PTEN/MMAC1 mutations in endometrial cancers Cancer Res 57 1997 4736 4738 (Pubitemid 27468978)
14. K. Oda, D. Stokoe, Y. Taketnni, and F. McCormik High frequency of coexistent mutations of PIK3CA and PTEN genes in endometrial carcinoma Cancer Res 65 2005 10669 10673 (Pubitemid 41713332)
15. M.P. Hayes, H. Wang, and R. Espinal-Witter PIK3CA and PTEN mutations in uterine endometrioid carcinoma and complex atypical hyperplasia Clin Cancer Res 12 2006 5932 5935 (Pubitemid 44703751)
16. A. Velasco, E. Bussaglia, and J. Pallares PIK3CA gene mutations in endometrial carcinoma. Correlation with PTEN and K-RAS alterations Hum Pathol 37 2006 1465 1472 (Pubitemid 44584324)
17. L. Catasus, A. Gallardo, M. Cuatrecasas, and J. Part PIK3CA mutations in the kinase domain (exon 20) of uterine endometrial adenocarcinomas are associated with adverse prognostic parameters Mod Pathol 21 2008 131 139 (Pubitemid 351172164)
18. K. Oda, J. Okada, and L. Timmerman PIK3CA cooperates with other phosphatidylinositol 3′-kinase pathway mutations to effect oncogenic transformation Cancer Res 68 2008 8127 8136
19. B.I. Bertelsen, S.J. Steine, R. Sandvei, A. Molven, and O.D. Laerum Molecular analysis of the PI3K-AKT pathway in uterine cervical neoplasia: frequent PIK3CA amplification and AKT phosphorylation Int J Cancer 118 2006 1877 1883
20. S. Kang, S.S. Seo, H.J. Chang, C.W. Yoo, S.Y. Park, and S.M. Dong Mutual exclusiveness between PIK3CA and KRAS mutations in endometrial carcinoma Int J Gyn Cancer 18 2008 1339 1343
21. T. Miyake, K. Yoshino, and T. Enomoto PIK3CA gene mutations and amplifications in uterine cancers, identified by methods that avoid confounding by PIK3CA pseudogene sequences Cancer Lett 261 2008 120 126
22. R.E. Scully, T.A. Bonfiglio, R.J. Kurman, S.G. Silverberg, and E.J. Wilkinson Histological typing of female genital tract tumors, in WHO: international histological typing of tumors 1994 Springer Berlin, Germany 14 27
23. W.T. Creasman Revision in classification by International Federation of Gynecology and Obstetrics Am J Obstet Gynecol 167 1992 857 858
24. V.S.W. Li, C.W. Wong, and T.S. Chan Mutations of PIK3CA in gastric adenocarcinoma BCM Cancer 2005 5
25. B. Konopka, A. Janiec-Jankowska, and D. Czapczak Molecular genetic defects in endometrial carcinomas: microsatellite instability, PTEN and beta-catenin (CTNNB1) genes mutations J Cancer Res Clin Oncol 133 2007 361 371 (Pubitemid 46716700)
26. L. Zhao, P.K. Vogt, and I. Class PI3K in oncogenic cellular transformation Oncogene 27 2008 5486 5496
27. M.P. Hayes, W. Douglas, and L.H. Ellenson Molecular alterations of EGFR and PIK3CA in uterine serous carcinoma Gynecol Oncol 113 2009 370 373
28. M. Ollikainen, A. Gylling, and M. Puputti Patterns of PIK3CA alterations in familial colorectal and endometrial carcinoma Int J Cancer 121 2007 915 920 (Pubitemid 47106226)
29. G. Wu, M. Xing, and E. Mambo Somatic mutation and gain copy number of PIK3CA in human breast cancer Breast Cancer Res 7 2005 609 616
30. M. Frattini, S. Signoroni, and S. Pilotti Phosphatase protein homologue to tensin expression and phosphatidylinosotol-3 phosphate kinase mutations in colorectal cancer Cancer Res 65 2005 11227 (Pubitemid 41713394)
31. L.H. Saal, K. Holm, and M. Maurer PIK3CA mutations correlate with hormone receptor, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma Cancer Res 65 2005 2554 2559 (Pubitemid 40490050)
32. D.K. Broderick, C. Di, and T.J. Parret Mutation of PIK3Ca in anaplastic oligodendrogliomas, high-grade astrocytomas, and medulloblastomas Cancer Res 64 2004 5048 5050 (Pubitemid 39006515)
33. S. Velho, C. Oliveira, and A. Ferreira The prevalence of PIK3CA mutations in gastric and colon cancer Eur J Cancer 41 2005 1649 1654 (Pubitemid 40981849)
34. J. Willner, K. Wurz, and K.H. Allison Alternate molecular genetic pathways in ovarian carcinomas of common histological types Hum Pathol 38 2007 607 613 (Pubitemid 46399888)
35. D.S. Byun, K. Cho, and B.K. Ryu Frequent monoallelic deletion of PTEN and its reciprocal association with PIK3CA amplification in gastric carcinoma Int J Cancer 104 2003 318 327 (Pubitemid 36249814)